BR9507683A - Derivados de adenosina - Google Patents

Derivados de adenosina

Info

Publication number
BR9507683A
BR9507683A BR9507683A BR9507683A BR9507683A BR 9507683 A BR9507683 A BR 9507683A BR 9507683 A BR9507683 A BR 9507683A BR 9507683 A BR9507683 A BR 9507683A BR 9507683 A BR9507683 A BR 9507683A
Authority
BR
Brazil
Prior art keywords
adenosine derivatives
adenosine
derivatives
Prior art date
Application number
BR9507683A
Other languages
English (en)
Inventor
Fulvio Gadient
Bonnie L K Mangold
John R Fozard
Mahavir Prashad
Prasad K Kapa
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9409324A external-priority patent/GB9409324D0/en
Priority claimed from GB9416693A external-priority patent/GB9416693D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of BR9507683A publication Critical patent/BR9507683A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BR9507683A 1994-05-10 1995-05-09 Derivados de adenosina BR9507683A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9409324A GB9409324D0 (en) 1994-05-10 1994-05-10 New organic compounds, their preparation and use
US24991494A 1994-05-26 1994-05-26
GB9416693A GB9416693D0 (en) 1994-08-18 1994-08-18 Improvements in or relating to organic compounds
PCT/US1995/005802 WO1995030683A1 (en) 1994-05-10 1995-05-09 Adenosine derivatives

Publications (1)

Publication Number Publication Date
BR9507683A true BR9507683A (pt) 1997-09-23

Family

ID=27267177

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9507683A BR9507683A (pt) 1994-05-10 1995-05-09 Derivados de adenosina

Country Status (13)

Country Link
EP (1) EP0759925A1 (pt)
JP (1) JPH09512823A (pt)
CN (1) CN1147815A (pt)
AU (1) AU2546195A (pt)
BR (1) BR9507683A (pt)
CA (1) CA2186847A1 (pt)
CZ (1) CZ327896A3 (pt)
FI (1) FI964468A (pt)
HU (1) HUT75338A (pt)
NO (1) NO964735L (pt)
PL (1) PL316985A1 (pt)
SK (1) SK146096A3 (pt)
WO (1) WO1995030683A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110902A (en) * 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
GB0228723D0 (en) 2002-12-09 2003-01-15 Cambridge Biotechnology Ltd Treatment of pain
GB0305149D0 (en) * 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Compounds for the treatment of pain
EP2021350B1 (en) 2006-03-21 2016-12-21 Rheinische Friedrich-Wilhelms-Universität Bonn Phosphorylated a2a receptor agonists
CN108822174A (zh) * 2018-08-29 2018-11-16 上海兆维科技发展有限公司 新型核苷修饰物2’-eoe-鸟嘌呤核苷及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729994D0 (en) * 1987-12-23 1988-02-03 Glaxo Group Ltd Chemical compounds
GB2226027B (en) * 1988-12-13 1992-05-20 Sandoz Ltd Adenosine derivatives,their production and use
US5017578A (en) * 1989-06-09 1991-05-21 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
DK62692D0 (pt) * 1992-05-14 1992-05-14 Novo Nordisk As

Also Published As

Publication number Publication date
EP0759925A1 (en) 1997-03-05
HUT75338A (en) 1997-05-28
HU9603105D0 (en) 1997-01-28
CZ327896A3 (en) 1997-03-12
CA2186847A1 (en) 1995-11-16
CN1147815A (zh) 1997-04-16
NO964735L (no) 1997-01-10
WO1995030683A1 (en) 1995-11-16
JPH09512823A (ja) 1997-12-22
FI964468A0 (fi) 1996-11-06
AU2546195A (en) 1995-11-29
PL316985A1 (en) 1997-03-03
SK146096A3 (en) 1997-07-09
FI964468A (fi) 1996-11-06
NO964735D0 (no) 1996-11-08

Similar Documents

Publication Publication Date Title
PT833828E (pt) Derivados de rapamicina
PT934320E (pt) Derivados de naftiridina
PT891332E (pt) Derivados de 6-fenilpiridil-2-amina
DE69522717D1 (de) Chinazolinderivate
DE122009000076I1 (de) Chinazolin-derivate
NO952854D0 (no) 1-arylpyrimidin-derivater
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
BR9611834A (pt) Derivados de oximetóxi-3-aril-pirona
BR9605434A (pt) Derivados de purin-6-ona
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
BR9709065A (pt) Derivados de alquilaminobenzotiazole e-benzoxazol
BR9509793A (pt) Derivados de tiofeneno
ATE231508T1 (de) Azyklische nukleosidderivate
DE69430587T2 (de) Pyrimidin-acyclonukleosid-derivate
ATA100695A (de) Prothrombin-derivate
PT856007E (pt) Derivados de ciclopeptidos
BR9610597A (pt) Derivados de diarilalcenilamina
DE69527786T2 (de) Diaminomethyliden-derivate
PT906279E (pt) Derivados de pirrol
DE59607054D1 (de) 4-Amino-benzoylguanidin-Derivate
DE59610106D1 (de) Fluorbenzylether-Derivate
ATE177102T1 (de) Chromanderivate
BR9507683A (pt) Derivados de adenosina
BR9506618A (pt) Derivados de difeniloxazolinas
PT843675E (pt) Derivados de aza-antraciclinona

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law